ABHD18 degrades cardiolipin by stepwise hydrolysis of fatty acids
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.110237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Mindong Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, New York University Grossman School of Medicine, New York, New York, USA. Electronic address: mindong.ren@nyulangone.or…. Hauptthemen laut MEDLINE: Cardiolipins, Fatty Acids, Drosophila Proteins, Proteolysis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Cardiolipin (CL), the signature phospholipid of mitochondria, carries four fatty acids that are remodeled after de novo synthesis. In yeast, remodeling is accomplished by the joint action of Cld1, a lipase that removes a fatty acid from CL, and Taz1, a transacylase that transfers a fatty acid from another phospholipid to monolysocardiolipin (MLCL). While taz1 homologs have been identified in all eukaryotes, cld1 homologs have remained obscure. Here, we demonstrate that α/β-hydrolase domain 18 (ABHD18), a highly conserved protein of plants, animals, and humans, is functionally homologous to Cld1. Knockdown of Abhd18 decreased the concentration of MLCL in murine, Taz-knockout myoblasts. Inactivation of Abhd18 in Drosophila substantially increased the abundance of CL. Abhd18 inactivation also reversed the increase in the rate of CL degradation, as measured with 13C isotopes, and the accumulation of deacylated CLs, such as MLCL and dilyso-CL, in tafazzin (TAZ)-deficient flies. CL species with more than five double bonds were resistant to ABHD18. Our data demonstrate that ABHD18 is the elusive lipase that hydrolyzes CL in mice and flies and presumably in other organisms. Rather than removing just one fatty acid, we show that ABHD18 deacylates CL further. Thus, ABHD18 catalyzes the breakdown of CL, whereas TAZ protects CL from degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, New York University Grossman School of Medicine, New York, New York, USA. Electronic address: mindong.ren@nyulangone.org.
- Department of Anesthesiology, New York University Grossman School of Medicine, New York, New York, USA.
- Department of Biological Sciences, Wayne State University, Detroit, Michigan, USA.
- Department of Anesthesiology, New York University Grossman School of Medicine, New York, New York, USA. Electronic address: michael.schlame@med.nyu.edu.
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- National Institutes of Health
- NIH National Institute of General Medical Sciences
Zitieren
APA
Ren, M., Chen, S., Greenberg, M. L., & Schlame, M. (2025). ABHD18 degrades cardiolipin by stepwise hydrolysis of fatty acids. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110237
Vancouver
Ren M, Chen S, Greenberg ML, Schlame M. ABHD18 degrades cardiolipin by stepwise hydrolysis of fatty acids. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110237
BibTeX
@article{Ren2025,
author = {Ren, Mindong and Chen, Shiyu and Greenberg, Miriam L and Schlame, Michael},
title = {ABHD18 degrades cardiolipin by stepwise hydrolysis of fatty acids},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.110237}
}
EUVIMED